JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Fortress Biotech Inc

Gesloten

1.91 4.37

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.8

Max

1.93

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+281.77% upside

Dividenden

By Dow Jones

Volgende Winsten

18 aug 2025

Fortress Biotech Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 mrt 2025, 02:12 UTC

Acquisities, Fusies, Overnames

Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY

10 mrt 2025, 02:12 UTC

Acquisities, Fusies, Overnames

Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY

10 mrt 2025, 02:11 UTC

Acquisities, Fusies, Overnames

Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY

10 mrt 2025, 02:11 UTC

Acquisities, Fusies, Overnames

Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY

10 mrt 2025, 02:10 UTC

Acquisities, Fusies, Overnames

Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY

10 mrt 2025, 02:10 UTC

Acquisities, Fusies, Overnames

Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT

10 mrt 2025, 02:06 UTC

Acquisities, Fusies, Overnames

Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT

Peer Vergelijking

Prijswijziging

Fortress Biotech Inc Prognose

Koersdoel

By TipRanks

281.77% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 7.33 USD  281.77%

Hoogste 16 USD

Laagste 2 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Financieel

$